✦ LIBER ✦

The economic burden of acute coronary syndrome: Health care and productivity costs

✍ Scribed by Ghushchyan, V.H.; Page, R.L.; Gifford, B.; Read, R.A.; Naim, A.B.; Raut, M.; Crivera, C.; Damaraju, C.V.; Nair, K.V.

Book ID: 122267556
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 73 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The economic burden of rheumatoid arthri

The economic burden of rheumatoid arthritis: beyond health care costs

✍ Wei Zhang; Aslam H. Anis 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 178 KB

Follow-On Health Care Costs in Patients

Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)

✍ Berger, A.; LaPensee, K.; Oster, G. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCV13 CLOPIDOGREL THERAPY AND HEALTH CAR

PCV13 CLOPIDOGREL THERAPY AND HEALTH CARE COSTS FOLLOWING AN ACUTE CORONARY SYNDROME EVENT

✍ SS Shetty; PL McCollam; G Gomez-Rey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PCV34 The Economic Cost of Acute Coronar

PCV34 The Economic Cost of Acute Coronary Syndrome in Turkey

✍ B. Cakir; Z. Caliskan; H. Ergun; C. Erol; B. Gumusel; L. Tokgozoglu; M. Dayioglu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCV121 The Economic and Humanistic Burde

PCV121 The Economic and Humanistic Burden of Acute Coronary Syndrome (ACS): A Systematic Review

✍ S. Weir; M. Ratcliffe; P. Mollon; S. Langham; D. Ossa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Estimating production costs in the econo

Estimating production costs in the economic evaluation of health-care programs

✍ Carmen Herrero; Juan D. Moreno-Ternero 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 3 views

## Abstract We propose a method for calculating the production costs of an intervention in a manner that accounts for differences in productive ‘effort.’ This method could be used within a cost‐effectiveness analysis framework in the evaluation of new medical technologies, pharmaceuticals, treatmen